Will DefenCath Continue to Aid CorMedix's Top Line in Q4 Earnings?Zacks Investment Research • 01/15/26
Lost Money on CorMedix Inc. (CRMD)? Contact Levi & Korsinsky About Fraud InvestigationNewsfile Corp • 01/14/26
CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/09/26
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business UpdatesGlobeNewsWire • 01/08/26
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCathGlobeNewsWire • 12/18/25
Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect?Zacks Investment Research • 12/09/25
CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 12/08/25
CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold RatingSeeking Alpha • 11/14/25
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate UpdatePRNewsWire • 11/12/25
CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 GuidanceGlobeNewsWire • 11/12/25
Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Here's What You Should KnowZacks Investment Research • 11/10/25